We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Novel Inexpensive, Shelf-Stable, Easy To Use Tests Bring Lab-Level Precision at POC

By LabMedica International staff writers
Posted on 22 May 2024
Print article
Image: Users draw blood with a simple fingerprick at home and mail the card to a lab for white blood cell counts (Photo courtesy of Charlie Mace)
Image: Users draw blood with a simple fingerprick at home and mail the card to a lab for white blood cell counts (Photo courtesy of Charlie Mace)

One of the most critical measurements in healthcare is the blood cell count, which can provide insights into a range of conditions from infections and autoimmune diseases to cancer. Traditionally, collecting a sample for this test involves a blood draw that must be performed at a clinic and analyzed in a centralized clinical laboratory. This requirement can be a significant barrier for homebound individuals or those living in remote areas. Now, researchers have simplified the process to just a finger prick, with blood collected on a paper-dried blood spot card that can be mailed to a lab for analysis, including measurement of white blood cell counts.

Researchers at Tufts University (Medford, MA, USA) are developing methods to perform these tests that significantly reduce costs and increase accessibility. They are utilizing a widely available resource: paper. Their groundbreaking paper-based tests for personal health monitoring do away with the need for costly lab equipment and can be used by anyone, anywhere. These paper analytical devices are inexpensive to produce, can be stored for extended periods, and are easily distributed for use in isolated locations, allowing for critical health data collection at the time and place it's most needed. The team has developed a device known as a patterned dried blood spot card, which features channels and collection zones that precisely measure and dry specific volumes of blood for later analysis. Users simply need to draw blood with a finger prick at home and mail the card to a laboratory, where the amount of DNA unique to white blood cells is measured to determine cell counts.

Additionally, the researchers have developed a paper analytical device to measure lactate, also known as lactic acid, in sweat. Lactate levels can signify oxygen deficiency and serve as a mortality predictor in trauma patients. For athletes or those working in physically demanding environments, lactate also measures muscle fatigue and fitness levels. This device uses bioreactive inks made from silk fibroin—a component of silk fibers—and enzymes that react with lactate to induce a color change. These inks are applied to small paper tabs that adhere to the skin with a common transparent wound dressing film. The tabs change color from yellow to dark red depending on lactate concentration in the sweat, with color changes captured and analyzed using a smartphone camera, achieving accuracy comparable to sophisticated lab equipment.

“People in remote and low-income regions tend to have reduced access to healthcare, which makes it all the more important to come up with cheaper and easier ways for them to monitor indicators of health,” said Charlie Mace, associate professor of chemistry. “This technology is likely to have additional applications in infectious disease such as detecting levels of virus and parasites in the blood and more generally in detecting markers of health and wellness.”

Related Links:
Tufts University

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Liquid Ready-To-Use Lp(a) Reagent
Lipoprotein (a) Reagent

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.